Minds for Sale
Jonathan Zittrain is a Professor of Law at Harvard Law School, Professor of Computer Science at the Harvard School of Engineering and Applied Sciences, Vice Dean for Library and Information Resources for the Harvard Law School Library, and Co-Founder of the Berkman Center for Internet & Society. Previously, he was the Chair in Internet Governance and Regulation at Oxford University and a principal of the Oxford Internet Institute. He was also a visiting professor at the New York University School of Law and Stanford Law School.
Zittrain’s research interests include battles for control of digital property and content, cryptography, electronic privacy, the roles of intermediaries within Internet architecture, and the useful and unobtrusive deployment of technology in education.
He is also the author of The Future of the Internet and How to Stop It, as well as co-editor of the books, Access Denied (MIT Press, 2008), Access Controlled (MIT Press, 2010), and Access Contested (MIT Press, 2011).
Jonathan Zittrain, speaking at the 2012 Nantucket Project, describers how crowdsourcing is being used to solve all kinds of problems, and how it can be used for good and well as evil purposes.
In a metaphor too apt to be made up, the council has been forced to relocate until the flood waters recede.
- The City of Venice is currently enduring the worst flooding to strike it in 50 years.
- The mayor has declared it to be a result of climate change.
- During a debate over next years budget, and right after rejecting environmental proposals, the main chamber of the regional council flooded.
The Von Braun Space Station, based on the concepts of a controversial scientist, is moving ahead with construction plans.
- The Gateway Foundation is building a space hotel, based on the concepts of a Nazi and American rocket scientist Wernher von Braun.
- The space station is expected to be operational by 2025.
- The company plans to assemble it in orbit, using robots and drones.
The vaccine is 97.5% effective in protecting against the Zaire species of Ebola, according to the World Health Organization.
- The European Medicines Agency granted special approval for an Ebola vaccine called Ervebo.
- Ervebo has proven remarkably effective in clinical trials conducted in Africa.
- An Ebola outbreak has killed more than 2,000 people in the Democratic Republic of Congo since August 2018.